dr reddy's glp-1 drugs portfolio 2025 Dr. Laboratories has received approval from Health Canada for its generic semaglutide injection, strengthening the Indian drugmaker's presence in the fast-growing global market for diabetes therapies. The company said on Dr. Reddy's Launches Oral Semaglutide

Mood and Mindset Balanced: Stay dialed in and less reactivethanks to ingredients that not only target physical hunger but support emotional regulation and neurotransmitter balance, helping you stay in control, even under pressure

Beyond modest lipid improvements, GLP-1 receptor agonists have demonstrated substantial cardiovascular benefits in large-scale outcome trials, establishing them as important cardioprotective agents for appropriate patients

Lyophilised AOD-9604 should be stored at 20 C protected from light, stability 2 to 3 years

The fluoride ion release from ion-releasing dental materials after surface loading by topical treatment with sodium fluoride gel